• 7232 Citations

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research interests

I am a practicing Gynecologic Oncologist on faculty at Washington University and currently serve as the Director of the Gynecologic Oncology Fellowship. I am the national/international study chair for three Gynecologic Oncology Group (GOG) trials: GOG 232B (completed), GOG 261 (ongoing), and GOG 229I (recently completed) involving the management of women with uterine cancer (Also Co-PI of GOG 232C). I have the expertise, leadership and motivation necessary to successfully carry out the work proposed within this SPORE application. I have a broad background in clinical trial development with the above GOG trials, with specific training and expertise in key research areas of translation research. I’ve had basic laboratory experience during my University of Washington NORCUS fellowship and during the one year of dedicated research spent in Dr. Paul Goodfellow’s laboratory during my gynecologic oncology fellowship.

Areas of Clinical Interest

Gynecologic oncology, endometrial cancer, vulva carcinoma, ovarian cancer, cervical cancer, adnexal masses, tumors, hysterectomy, lymphadenectomy, endometrial adenocarcinomas, cervical intraepithelial neoplasia, gynecologic malignancies, ob/gyn, women's health

Fingerprint Dive into the research topics where Matthew Powell is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • A randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancer

    Vergote, I., Heitz, F., Buderath, P., Powell, M., Sehouli, J., Lee, C. M., Hamilton, A., Fiorica, J., Moore, K. N., Teneriello, M., Golden, L., Zhang, W., Pitou, C., Bell, R., Campbell, R., Farrington, D. L., Bell-McGuinn, K. & Wenham, R. M., Jan 2020, In : Gynecologic oncology. 156, 1, p. 23-31 9 p.

    Research output: Contribution to journalArticle

    Open Access
  • 3 Scopus citations

    Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study

    Tewari, K. S., Sill, M. W., Coleman, R. L., Aghajanian, C., Mannel, R., DiSilvestro, P. A., Powell, M., Randall, L. M., Farley, J., Rubin, S. C. & Monk, B. J., 2020, (Accepted/In press) In : Gynecologic oncology.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer®-accredited facilities

    Vaz, J., Tian, C., Richardson, M. T., Chan, J. K., Mysona, D., Rao, U. N., Powell, M. A., Shriver, C. D., Hamilton, C. A., Casablanca, Y., Maxwell, G. L. & Darcy, K. M., Apr 2020, In : Gynecologic oncology. 157, 1, p. 121-130 10 p.

    Research output: Contribution to journalArticle